Explore

2nd Neuroimmunology Drug Development Summit

2nd Neuroimmunology Drug Development Summit 2020

The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
15 - 17 April 2020
The conference ended on 17 April 2020

Important Dates

Abstract Submission Deadline
14th April 2020

About 2nd Neuroimmunology Drug Development Summit

Translating Neuroimmunological into Clinically Effective Neurodegenerative Targeting Therapeutics

Topics

Health and medicine

Call for Papers

The Industry's Definitive Conference Specifically Designed to Overcome the Translational Challenges of Neuroimmunological Drug Development

Focused on neurodegenerative diseases such as Parkinson's, Alzheimer's and ALS, and with over 23 speakers from leading drug developers including Biogen, Alector, andJanssen, the 2nd Annual Neuroimmunology Drug Development Summit will enable you to:

- Discover the latest advances in recapitulating human microglia in preclinical models to reduce the translational gap

- Hear about the successful investment strategies helping small biotechs to pursue novel targets

- Discuss how to approach neuroimmunological targets to improve the efficacy of neurodegenerative therapeutics

- Review the latest clinical data with neuroimmunological candidates to inform future research

- Network with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations

Join over 80 members the neuroimmunology drug development community for an unrivaled learning and networking experience with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations.

Time: 09:00 to 17:00

Speakers: Andrea Crotti, Astellas, Anindya Bhattacharya, Janssen, Christian Haass, University of Munich, David Hansen, Genentech, Dimitry Ofengeim, Sanofi, Eduard Urich, Roche, Jamie Bilsland, AstronauTx, Jane Osbourn, Alchemab, Johan Luthman, Lundbeck, Jonathan Behr, Dementia Discovery Fund, Karel Otero-Gutierrez, Eisai, Karpagam Shalu Srinivasan, Alector, Malu Tansey, The University of Florida College of Medicine, Maria Carrillo, Alzheimer’s Association, Matt Blurton-Jones, University of California, Irvine, Matthew Fell, Merck Research Laboratories, Rebecca Mathew, Merck Research Laboratories, Richard Ransohoff, Third Rock Ventures, RJ Tesi, INmune Bio, Robert Paul, Alector, Sue Bruhn, Tiaki Therapeutics

Prices: Conference + 2 Workshops: USD 4297.00, Conference + 1 Workshop: USD 3698.00, Conference Only: USD 3099.00, Workshop Only: USD 699.00

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.